Blog
Hitting the Target With NGS Advances
BlogThis year’s Advances in Genome Biology and Technology meeting showcased some of the most exciting developments in genomic technology. We caught up with Twist Bioscience CEO Emily Leproust to discuss the importance of target enrichment in next generation sequencing and the advancements in the field that caught her eye at AGBT.
Proteogenomics, Precision Medicine and Oncology
BlogMajor advances have occurred in the fields of proteomics and genomics over recent years. Now, scientists are utilizing the technologies from each approach collectively in a novel research area named proteogenomics. We spoke with Alexzander Asea, Professor and Director at Precision Therapeutics Proteogenomics Diagnostics Center, University of Toledo, to learn more about the applications of proteogenomics in precision medicine.
Read More
Keeping Cell and Gene Therapies Alive in Transit
BlogCryoport is the single largest cryogenic delivery system for immunotherapy drugs, and the sole cryogenics logistics provider for the first two commercialized cell therapies. To learn more about the company providing the logistics backbone of clinical trials for regenerative medicine, we caught up with Mark Sawicki, chief commercial officer.
Read More
Calculating Gestational Age With Metabolomics
BlogResearchers have developed a mathematical model that may offer an alternative to relying on ultrasound information for calculating gestational age. The model, utilizing a "metabolomic fingerprint" approach, may overcome barriers in preterm death research.
Read More
Proteomics Experts Unite for EPIC-XS
BlogThe European Proteomics Infrastructure Consortium providing access (EPIC-XS) consists of a network of experienced research groups that share one common goal: to facilitate the development and sustainability of proteomics explorations to researchers within the European Union. We spoke with Martina O’Flaherty from the EPIC-XS project office to learn more.
Read More
Flow Chemistry: Successfully Transitioning From Lab to Production
BlogAs continuous flow technology takes center stage, we are seeing a transformation in chemical production. To learn more about the transition away from batch-wise approaches to chemical reactions, the advantages and challenges of using flow technology, and how its adoption has impacted the industry we recently spoke with Charlotte Wiles, PhD, CEO at Chemtrix BV.
Read More
“Mastermind” Scientists Help Diagnose Rare Diseases
BlogThe Rare Genomics Institute announced on Rare Disease Day 2019 that they had used the Mastermind Genomic Search Engine, a clinical decision support tool by Genomenon, to diagnose a rare disease patient. We spoke to Mark Kiel, MD, PhD, Founder and Chief Science Officer at Genomenon and Romina Ortiz, COO at the Rare Genomics Institute, to learn more about the application of this technology in rare diseases.
Read More
Developing Scalable Flow Chemistry for a Variety of Chemical Transformations
BlogWe recently spoke to Oliver Kappe to learn more about his research. Kappe highlights the key properties of continuous-flow microreactors that make them well-suited to preparing pharmaceuticals.
Read More
No One Size Fits All: The Challenges of Vendor Agnostic Software
BlogBiosero, Inc. develop automation software, that deploys artificial intelligence to speed up critical lab work. We caught up with David Dambman, Biosero’s Director of Engineering, to talk about the challenges of developing agnostic software, and how labs can implement artificial intelligence into their processes.
Read More
Tiny Protein Has Huge Potential in CRISPR
BlogLast year the smallest CRISPR protein, Cas14 was discovered. We spoke to the scientists that made the discovery, Lucas Harrington, at Mammoth Biosciences, to learn more about Cas14.
Read More
